Lupin Ltd

Entity type image
Type: Company
Name: Lupin Ltd (Lupin Limited)
Nationality: India
Fact Sheet: Fact Sheet for Lupin Limited
First reported May 20 2013 - Updated May 21 2013 - 1 reports
Dr Reddy's Laboratories Ltd
Dr Reddy's Laboratories Ltd

Sensex snaps 4-day rally, down 62 points on profit selling

Falling for the first time in five sessions, the BSE benchmark Sensex today retreated from 30-month high levels by losing 62 points to end at 20,223.98 on profit-booking in recent gainers in healthcare, consumer durable and banking sectors.After a steady ... [Published Financial Chronicle - May 20 2013]
First reported May 20 2013 - Updated May 20 2013 - 1 reports

Lupin shares dip after Mylan's generic drug hit US market

Image via ShutterstockShares of Lupin Ltd have plunged by 4.5% on BSE following the launch of rival Mylan Inc's generic version of the cholesterol-lowering  Tricor  ( Fenofibrate )  tablets. ... [Published Business Standard India - May 20 2013]
First reported May 20 2013 - Updated May 20 2013 - 1 reports
Credit Suisse Group AG
Credit Suisse Group AG

Lupin Plunges Most in 2 Years as Credit Suisse Downgrades Stock

Lupin Ltd. (LPC) is poised for its biggest drop in more than two years after brokerages including Credit Suisse Group AG cut their recommendation on the stock of the drugmaker controlled by Indian billionaire Desh Bandhu Gupta.The shares slumped 4.6 percent ... [Published Bloomberg - May 20 2013]
First reported May 20 2013 - Updated May 20 2013 - 3 reports
Mylan Incorporated
Mylan Incorporated

Lupin falls nearly 5% on Mylan drug launch, downgrade

NEW DELHI: Shares in Lupin Ltd slump nearly 5 per cent following the launch of rival Mylan Inc's generic version of the cholesterol-lowering Tricor tablets.Earlier in the day, Credit Suisse downgraded Lupin from 'outperform' to 'neutral' rating as risk ... [Published Economic Times - May 20 2013]
First reported May 17 2013 - Updated May 17 2013 - 2 reports

Drugmakers fall on government price control policy Reuters

Reuters Market Eye - The NSE Pharma index falls 0.93 percent after the government formally notified a new drug pricing policy designed to increase the number of drugs deemed essential that are subject to price caps.The policy, which will curtail prices ... [Published Yahoo! Finance - May 17 2013]
First reported May 13 2013 - Updated May 13 2013 - 1 reports
New Delhi (India)
New Delhi (India)

Lupin plans to launch 20-25 products every year into US market

NEW DELHI: Drug major Lupin Ltd likely to launch 20-25 products in the American market every year in the next couple of years. Lupin is the fifth largest generics player in the US market.read more ... [Published IndiaMart - May 13 2013]
First reported May 12 2013 - Updated May 12 2013 - 1 reports
IMS Health Inc
IMS Health Inc

Lupin expects to launch 20-25 products every year in the US

New Delhi: Drug major Lupin Ltd, the fifth largest generics player in the US, expects to launch 20-25 products in the American market every year in the next couple of years.The Mumbai-based firm, which is aiming to further consolidate its business in ... [Published zeenews.com - May 12 2013]
First reported May 08 2013 - Updated May 08 2013 - 3 reports

Lupin Ltd. Q4 net profit zooms to Rs 408 cr, Nilesh Gupta to be new MD

Net sales of the company rose to Rs 2,537.4 crore for the quarter, Lupin Ltd. said in a statement. ... [Published Indian Express - May 08 2013]
First reported May 07 2013 - Updated May 08 2013 - 9 reports

Lupin firms up after healthy Q4 numbers

Lupin rose 2.47% to Rs 731 at 15:25 IST on BSE after the company reported strong Q4 March 2013 results during trading hours today, 8 May 2013. Meanwhile, the BSE Sensex was up 123.63 points, or 0.62%, to 20,012.58.On BSE, 4.05 lakh shares were traded ... [Published India Infoline - May 08 2013]
Entities: Lupin Ltd, EBITDA, India
First reported May 08 2013 - Updated May 08 2013 - 2 reports

Lupin operating profit may lag estimates - StarMine

Reuters Market Eye - Lupin Ltd may miss January-March operating profit consensus forecasts when it reports results later in the day, according to Thomson Reuters StarMine data. ... [Published Business Standard India - May 08 2013]
Entities: Lupin Ltd, Market
First reported May 03 2013 - Updated May 03 2013 - 2 reports

Weekahead: Mkts to focus on fund flows, monsoon

Technical indicators point towards some correction in equity markets next week as it seems to have become overbought after a 3.5 per cent rally in the benchmark index in April, traders say.Focus will now shift to the performance of monsoon rains in India ... [Published Economic Times - May 03 2013]
First reported Apr 27 2013 - Updated Apr 27 2013 - 2 reports

Lupin receives US FDA approval for its Oral Contraceptive Tablets

Lupin Ltd's subsidiary Lupin Pharmaceuticals Inc. has received final approval for its Pirmella 7/7/7 (Norethindrone and Ethinyl Estradiol Tablets USP, 0.5 mg/0.035 mg, 0.75 mg/0.035 mg and 1mg/0.035 mg) and Pirmella 1/35 Tablets (Norethindrone and Ethinyl ... [Published Equity Bulls - Apr 27 2013]

Quotes

"Markets opened on a strong note on firmness in global markets and surged to new highs. However, profit booking was seen...Auto stocks like M&M, Bajaj Auto and Maruti were in limelight and showed strength while healthcare and consumer durables indices lost more than one percent each" said Nidhi Saraswat, Senior Research Analyst, Bonanza Portfolio
Sensex snaps 4-day rally, down 62 points on profit selling [Published Financial Chronicle - May 20 2013]
"Mylan's launch of Tricor will result in higher competition and decline in Lupin's market share in a drug which has a market size of $1.2 billion" said Ranjit Kapadia, senior vice president at Centrum Broking
Lupin falls nearly 5% on Mylan drug launch, downgrade [Published Economic Times - May 20 2013]
...vel-playing field between integrated firms with end-to-end infrastructure and others that are virtual companies that hardly have any overhead costs. "The government in fact, needs to incentivize investment in manufacturing and research" added Mazumdar
New price regime to hurt drug industry revenue by 4-5% [Published Individual.com - May 18 2013]
...Sandoz Inc, the generic drug unit of Novartis, has been marketing its own Yaz alternative since 2011, and will reportedly continue to do so. "We disagree with the court's ruling and are evaluating our options" Bayer spokeswoman Astrid Kranz said in an email to Reuters...
Actavis to Sell Generic Yaz After Victorious Court Ruling; Irvine Personal Injury Lawyer Jeff Nad ... [Published PRWeb - May 14 2013]

More Content

All (111) | News (94) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (1) | Press Releases (15)
sort by: Date | Relevance
Wockhardt too a part of FDA toxic capsule [Published EHealth Magazine - May 24 2013]
The Zacks Analyst Blog Highlights: Zumiez, Myla... [Published FinanzNachrichten.de - May 23 2013]
Lupin shares dip after Mylan's generic drug hit... [Published Business Standard India - May 20 2013]
Sensex snaps 4-day rally, down 62 points on pro... [Published Financial Chronicle - May 20 2013]
Lupin Plunges Most in 2 Years as Credit Suisse ... [Published Bloomberg - May 20 2013]
Lupin falls nearly 5% on Mylan drug launch, dow... [Published Economic Times - May 20 2013]
Lupin falls; Mylan launches cholesterol drug [Published Business Standard India - May 20 2013]
Lupin falls; Mylan launches cholesterol drug Re... [Published Yahoo! Finance - May 20 2013]
New price regime to hurt drug industry revenue ... [Published Individual.com - May 18 2013]
Pharma cos fall on government price control policy [Published Economic Times - May 17 2013]
Drugmakers fall on government price control pol... [Published Yahoo! Finance - May 17 2013]
Drugmakers fall on government price control policy [Published Reuters India - May 17 2013]
Stock markets hit all time high [Published TruthDive - May 16 2013]
Sensex zooms; top 19 trading ideas for raging m... [Published Economic Times - May 15 2013]
Drug Maker Lupin Aims for the Cloud with Micros... [Published Softpedia - May 15 2013]
Actavis to Sell Generic Yaz After Victorious Co... [Published PRWeb - May 14 2013]
Pharma giant Lupin deploys Microsoft Office 365... [Published Information Week India - May 14 2013]
Lupin Limited Deployed Microsoft Office 365 [Published Communications Today - May 14 2013]
Just Published: Global Diabetic Retinopathy Mar... [Published MyNewsDesk - May 13 2013]
Lupin plans to launch 20-25 products every year... [Published IndiaMart - May 13 2013]
Lupin Reduces Costs With Microsoft Office 365 [Published BizTech2 India - May 13 2013]
Lupin sees 40% savings over 3 yrs on MS Office ... [Published India Infoline - May 13 2013]
Global Diabetic Retinopathy Market 2012-2016 | ... [Published MyNewsDesk - May 13 2013]
Lupin expects to launch 20-25 products every ye... [Published zeenews.com - May 12 2013]
Lupin elevates Vinita Gupta as CEO and Nilesh G... [Published Equity Bulls - May 12 2013]
Lupin posts net profit of Rs. 1314.16 crore in ... [Published Equity Bulls - May 12 2013]
Market at 2 year high; top 5 stocks to hit 52-w... [Published Economic Times - May 11 2013]
Lupin Ltd repeats yet another strong quarter, m... [Published Financial Express - May 10 2013]
The four big stock bets of Rakesh Jhunjhunwala [Published Smart Investor - May 10 2013]
Lupin rejigs top posts [Published Calcutta Telegraph - May 09 2013]
1 2 3 4
In Focus
  •  
Nilesh Gupta, Vinita Gupta, Rakesh Jhunjhunwala, [more]
  •  
Lupin Pharmaceuticals, Inc., Bayer AG, Mylan Incorporated, [more]
  •  
FDA Food & Drug Administration, United States Court of Appeals for the Federal ..., United States Courts of Appeals, [more]
  •  
Net Profit, Contraceptive Pill, Drugs, [more]
  •  
Microsoft Office 365, Seasonique, Suprax, [more]
  •  
Mumbai, New Delhi (India), Baltimore (Maryland, United States), [more]
  •  
India, United States, Japan, [more]
  •  
CBRN/WMD, Diseases, Narcotics, [more]
  •  
IT, Banking & Financial Services, Chemicals & Plastics, [more]
Topnews.in, Business Standard India, India Infoline, [more]
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Court Report [Published Patent Docs - Dec 03 2012]
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Takeda Pharmaceutical Co. et al. v. Lupin Ltd. et al. 3:12-cv-07333; filed November 29, 2012 in the District Court of New Jersey•Plaintiffs: ...
1

Press Releases

sort by: Date | Relevance
Lupin Launches bringt Daysee™-Pille zur Empfäng... [Published PR Newswire: Health - Apr 13 2013]
Lupin lance son contraceptif oral Daysee™ en co... [Published PR Newswire: Health - Apr 13 2013]
Lupin Launches its Oral Contraceptive Daysee™ T... [Published PR Newswire: Health - Apr 12 2013]
Lupin erhält Genehmigung der FDA für den Antrag... [Published PR Newswire: Policy & Public Interest - Feb 22 2013]
Lupin reçoit une approbation de la FDA concerna... [Published PR Newswire: General Business - Feb 22 2013]
1 2 3
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.